Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/12933| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Katerina Damevska | en_US |
| dc.contributor.author | Lence Neloska | en_US |
| dc.contributor.author | Gorgi Gocev | en_US |
| dc.contributor.author | Marija Mihova | en_US |
| dc.date.accessioned | 2021-05-31T09:07:15Z | - |
| dc.date.available | 2021-05-31T09:07:15Z | - |
| dc.date.issued | 2013-12 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/12933 | - |
| dc.description.abstract | Previous studies have shown a higher prevalence of metabolic syndrome in patients with psoriasis compared to controls. However, little attention has been paid to the effect of systemic anti-psoriatic drugs on the metabolic syndrome. The aim of this study was to investigate the association between psoriasis and the metabolic syndrome, by comparing untreated patients with psoriasis and population based control. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley Online Library | en_US |
| dc.relation.ispartof | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | en_US |
| dc.title | Metabolic syndrome in untreated patients with psoriasis: case-control study | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1111/ddg.12193 | - |
| dc.identifier.url | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fddg.12193 | - |
| dc.identifier.volume | 11 | - |
| dc.identifier.issue | 12 | - |
| item.fulltext | No Fulltext | - |
| item.grantfulltext | none | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.